New Psychonaut

View Original

Inner space of safety

Medical

MDMA boasts striking therapeutic properties beyond increased connection

Chemical X, ‘Spectrum’

“I believe MDMA is the ideal drug for psychotherapy,” says non-nonsense Awakn founder and trauma expert Dr Ben Sessa.

The exciting bits are MDMA triggers a ‘oxytocin-dependent reopening’ of a ‘social reward learning critical period’. It puts your brain in the state of early childhood and adolescence, when it establishes key neural pathways. The hypothesis is that dysfunctional thought patterns can be adjusted in this state.

MDMA increases pre-frontal cortex activity like an ADHD stimulant, lowers activity in the amygdala ‘fear centre’ deep in the reptile brain, and is notable for its relationship to both dopamine and serotonin. It creates an ‘optimal level of arousal’ that is neither too little nor too much for the brain to process its thoughts and instincts. 

Added neuroplasticity helps memories reconsolidate so patients feel safer in safe settings, for example. MDMA scored strongly on PTSD patients with dissociative symptoms who often prove the toughest to treat. Trial data was consistent across the five test sites spread globally. 

Ecstasy was first named ‘Adam’ then ‘Empathy’

Trial subjects previously suffered severe symptoms that had resisted regular therapeutic treatment for many years.

‘MDMA was invented for shellshocked soldiers’ is a trope I may be guilty of falling for. It wasn’t an appetite suppressant either when patented by Merck in 1914. Forensic research into the German pharmaceutical firm suggests a humbler origins for the love drug as merely a stepping-stone towards developing an alternative to hydrastinine, used to prevent internal bleeding particularly in the uterus.

The military nonetheless had it knocking around for whatever reason in the 1950s around the first time scientists tested MDMA on humans and recorded the results. These soon reached the keen ears of Alexander Shulgin, who says he first synthesised it in 1965. It was originally named ‘Adam’, and also ‘Empathy’. 

Patients during MDMA-AT are given 125mg of what the subculture renamed ‘ecstasy’ with up to 75mg of booster. Apocryphally, a friend who took part in an Imperial MDMA trial said it was hella strong.